Premier Alternatives

Anumana

Decision/Risk Analysis · Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care. Anumana is based in Cambridge, MA and was founded in 2021. It was valued at $580 million at its early-stage round in Mar 2025, the last priced event on record. It has raised $185 million across 3 recorded rounds; the latest was a $95.4 million early-stage round in Mar 2025.

PMV mark · valuation
$580.0M
Oct 2026
Priced at
its early-stage round
Mar 2025
Total raised
$185.3M
Last round
Early Stage VC
Mar 2025

Anumana key facts

as of Oct 2026
  • Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care.
  • Anumana is valued at approximately $580.0M as of Oct 2026, set at its early-stage round, Mar 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $185.3M across 3 recorded rounds; the latest was Early Stage VC ($95.4M) in Mar 2025.
  • Notable investors include MedTech Innovator, Matrix, Mayo Clinic, Mayo Clinic Ventures, Matrix Capital Management — 8 tracked in total.
  • Anumana has filed 1 Form D with the SEC, most recently Nov 2022 ($32.0M sold to 72 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$580.0M

Valued at $580.0M at its early-stage round, Mar 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Anumana with a free account
  • ·Watch Anumana: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Anumana funding rounds

3 rounds
Mar 2025Early Stage VC$95.4M▮
Nov 2022Early Stage VC$32.0MSEC filing▮
Apr 2021Early Stage VC (Series A)$25.7M▮
Full funding history →

Anumana valuation

Anumana was valued at $580 million at its early-stage round in Mar 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Anumana raised?

Anumana has raised $185 million across 3 recorded rounds since 2021. The largest was a $95.4 million early-stage round in Mar 2025.

Anumana has filed 1 Form D with the SEC, most recently in Nov 2022 ($32 million sold to 72 investors).

Anumana investors

8 investors are on record for Anumana, including MedTech Innovator, Matrix, Mayo Clinic and Mayo Clinic Ventures. The early-stage round in Mar 2025 drew 4 investors.

Comparable companies

Comparable decision/risk analysis names by valuation on PrivateMarketView: Freenome ($2.2 billion), HeartFlow (NAS: HTFL) ($1.5 billion) and VideaHealth ($400 million).

About Anumana

Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care. The company's platform integrates algorithms with existing clinical workflows, facilitating the transformation of unstructured data into actionable insights, enabling healthcare providers to identify hidden cardiovascular diseases early and improve patient outcomes through timely interventions.

Industry
Decision/Risk Analysis
Sector
Healthcare
HQ
Cambridge, MA, United States
Founded
2021
Employees
163
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.